Search
引用和文献 (17)
Gibco™
StemPro™-34 SFM (1X)
StemPro-34 SFM 是一种无血清培养基，专门配制用于支持人造血细胞在培养物中的生长，包括从骨髓、新生儿脐带血和外周血中分离的 HSC 和祖细胞。StemPro-34 SFM 是一种灵活的细胞培养基，可用于多种应用。了解更多信息
| 货号 | 数量 |
|---|---|
| 10639011 | 500 mL |
货号 10639011
价格（CNY)
4,994.00
飞享价
Ends: 27-Dec-2025
6,823.00共减 1,829.00 (27%)
Each
数量:
500 mL
价格（CNY)
4,994.00
飞享价
Ends: 27-Dec-2025
6,823.00共减 1,829.00 (27%)
Each
StemPro-34 SFM 是一种无血清培养基，专门配制用于支持人造血细胞在培养物中的生长，包括从骨髓、新生儿脐带血和外周血中分离的 HSC 和祖细胞。StemPro-34 SFM 是一种灵活的细胞培养基，可用于多种应用。
适用于人类离体组织和细胞培养处理应用。注意：作为医疗产品使用时，美国联邦法规限制医生销售此产品。
规格
细胞类型造血干细胞、造血细胞、骨髓
内毒素水平≤ 10 EU/mL
产品线StemPro
产品类型干细胞无血清培养基 (SFM)
数量500 mL
种属人
分类无血清
培养类型固定悬浮培养
形式液体
血清水平无血清
加有添加剂酚红
不加添加剂无谷氨酰胺
Unit SizeEach
内容与储存
• 500 mL StemPro™-34 无血清培养基（在黑暗环境中于 2°C 至 8°C 下储存）
•13 mL StemPro™-34 营养素补充剂（在黑暗环境中于 -5°C 至 -20°C 下储存）
完全培养基在黑暗环境中于 2°C 至 8°C 下储存。
•13 mL StemPro™-34 营养素补充剂（在黑暗环境中于 -5°C 至 -20°C 下储存）
完全培养基在黑暗环境中于 2°C 至 8°C 下储存。
引用和文献 (17)
引用和文献
Abstract
Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells.
Journal:Nature communications
PubMed ID:31628330
In the human hematopoietic system, rare self-renewing multipotent long-term hematopoietic stem cells (LT-HSCs) are responsible for the lifelong production of mature blood cells and are the rational target for clinical regenerative therapies. However, the heterogeneity in the hematopoietic stem cell compartment and variable outcomes of CRISPR/Cas9 editing make functional interrogation
Ex vivo expanded human cord blood-derived hematopoietic progenitor cells induce lung growth and alveolarization in injured newborn lungs.
Journal:Respiratory research
PubMed ID:23522153
BACKGROUND: We investigated the capacity of expanded cord blood-derived CD34+ hematopoietic progenitor cells to undergo respiratory epithelial differentiation ex vivo, and to engraft and attenuate alveolar disruption in injured newborn murine lungs in vivo. METHODS: Respiratory epithelial differentiation was studied in CD34+ cells expanded in the presence of growth factors
Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.
Journal:PloS one
PubMed ID:21364915
BACKGROUND: Differentiation of pluripotent stem cells in vitro provides a powerful means to investigate early developmental fates, including hematopoiesis. In particular, the use of a fully defined medium (FDM) would avoid biases induced by unidentified factors contained in serum, and would also allow key molecular mediators involved in such a
Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures.
Journal:Blood
PubMed ID:17148580
The onset of hematopoiesis in the mouse embryo and in the embryonic stem (ES) cell differentiation model is defined by the emergence of the hemangioblast, a progenitor with both hematopoietic and vascular potential. While there is evidence for the existence of a hemangioblast in the mouse, it is unclear if
Differentiation of Human-Induced Pluripotent Stem Cells to Macrophages for Disease Modeling and Functional Genomics.
Journal:Current protocols in stem cell biology
PubMed ID:30537374
Macrophages play important roles in many diseases. We describe a protocol and the associated resources for the differentiation of human induced pluripotent stem cell-derived macrophages (IPSDM) and their applications in understanding human macrophage physiology and relevant diseases. The protocol uses an embryoid bodyâbased approach with a combination of serum-free condition